Di Pompo G, Errani C, Gillies R, Mercatali L, Ibrahim T, Tamanti J
Front Cell Dev Biol. 2021; 9:678532.
PMID: 34124067
PMC: 8194084.
DOI: 10.3389/fcell.2021.678532.
Bartkowiak K, Koch C, Gartner S, Andreas A, Gorges T, Pantel K
Cells. 2020; 9(5).
PMID: 32466213
PMC: 7291257.
DOI: 10.3390/cells9051316.
Andersson P, Ostheimer C
Front Immunol. 2019; 10:2083.
PMID: 31555290
PMC: 6742972.
DOI: 10.3389/fimmu.2019.02083.
Gagnon D, Dorman S, Ritchie S, Mutt S, Stenback V, Walkowiak J
Front Physiol. 2019; 10:1123.
PMID: 31551806
PMC: 6733972.
DOI: 10.3389/fphys.2019.01123.
Vaziri-Gohar A, Zarei M, Brody J, Winter J
Front Oncol. 2019; 8:617.
PMID: 30631752
PMC: 6315177.
DOI: 10.3389/fonc.2018.00617.
CLEC14a-HSP70-1A interaction regulates HSP70-1A-induced angiogenesis.
Jang J, Kim M, Kim T, Lee W, Kim J, Heo K
Sci Rep. 2017; 7(1):10666.
PMID: 28878328
PMC: 5587741.
DOI: 10.1038/s41598-017-11118-y.
Gastric Cancer and Angiogenesis: Is VEGF a Useful Biomarker to Assess Progression and Remission?.
Macedo F, Ladeira K, Longatto-Filho A, Martins S
J Gastric Cancer. 2017; 17(1):1-10.
PMID: 28337358
PMC: 5362829.
DOI: 10.5230/jgc.2017.17.e1.
Cryptotanshinone potentiates the antitumor effects of doxorubicin on gastric cancer cells via inhibition of STAT3 activity.
Wang J, Zhang G, Dai C, Gao X, Wu J, Shen L
J Int Med Res. 2017; 45(1):220-230.
PMID: 28222632
PMC: 5536615.
DOI: 10.1177/0300060516685513.
Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule.
Owczarek T, Suchanski J, Pula B, Kmiecik A, Chadalski M, Jethon A
PLoS One. 2014; 8(12):e84191.
PMID: 24391908
PMC: 3877204.
DOI: 10.1371/journal.pone.0084191.
The complex function of hsp70 in metastatic cancer.
Juhasz K, Lipp A, Nimmervoll B, Sonnleitner A, Hesse J, Haselgruebler T
Cancers (Basel). 2013; 6(1):42-66.
PMID: 24362507
PMC: 3980608.
DOI: 10.3390/cancers6010042.
Evidence of multimeric forms of HSP70 with phosphorylation on serine and tyrosine residues--implications for roles of HSP70 in detection of GI cancers.
Dutta A, Girotra M, Merchant N, Nair P, Dutta S
Asian Pac J Cancer Prev. 2013; 14(10):5741-5.
PMID: 24289572
PMC: 4193537.
DOI: 10.7314/apjcp.2013.14.10.5741.
Oxidative and nitrosative stress in the metastatic microenvironment.
Ortega A, Mena S, Estrela J
Cancers (Basel). 2013; 2(2):274-304.
PMID: 24281071
PMC: 3835079.
DOI: 10.3390/cancers2020274.
A case-control study on the effect of Apolipoprotein E genotypes on gastric cancer risk and progression.
De Feo E, Simone B, Persiani R, Cananzi F, Biondi A, Arzani D
BMC Cancer. 2012; 12:494.
PMID: 23098561
PMC: 3537647.
DOI: 10.1186/1471-2407-12-494.
Heat stress induces epithelial plasticity and cell migration independent of heat shock factor 1.
Lang B, Nguyen L, Nguyen H, Vieusseux J, Chai R, Christophi C
Cell Stress Chaperones. 2012; 17(6):765-78.
PMID: 22791010
PMC: 3468677.
DOI: 10.1007/s12192-012-0349-z.
Apoptosis resistance and PKC signaling: distinguishing features of high and low metastatic cells.
Hong S, Ren L, Mendoza A, Eleswarapu A, Khanna C
Neoplasia. 2012; 14(3):249-58.
PMID: 22496624
PMC: 3323902.
DOI: 10.1593/neo.111498.
Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway.
Cooke V, LeBleu V, Keskin D, Khan Z, OConnell J, Teng Y
Cancer Cell. 2012; 21(1):66-81.
PMID: 22264789
PMC: 3999522.
DOI: 10.1016/j.ccr.2011.11.024.
Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.
Wu Q, Dhir R, Wells A
Mol Cancer. 2012; 11:3.
PMID: 22236567
PMC: 3320557.
DOI: 10.1186/1476-4598-11-3.
The interrelating dynamics of hypoxic tumor microenvironments and cancer cell phenotypes in cancer metastasis.
Bartkowiak K, Riethdorf S, Pantel K
Cancer Microenviron. 2011; 5(1):59-72.
PMID: 21626313
PMC: 3343196.
DOI: 10.1007/s12307-011-0067-6.
STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer.
Deng J, Sun D, Liu X, Pan Y, Liang H
World J Gastroenterol. 2010; 16(42):5380-7.
PMID: 21072904
PMC: 2980690.
DOI: 10.3748/wjg.v16.i42.5380.
Growth hormone releasing hormone induces the expression of nitric oxide synthase.
Barabutis N, Siejka A, Schally A
J Cell Mol Med. 2010; 15(5):1148-55.
PMID: 20518847
PMC: 3822627.
DOI: 10.1111/j.1582-4934.2010.01096.x.